Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Illumina Inc

ILMN
Current price
71.20 USD -0.16 USD (-0.22%)
Last closed 73.45 USD
ISIN US4523271090
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 11 637 069 824 USD
Yield for 12 month -39.13 %
1Y
3Y
5Y
10Y
15Y
ILMN
21.11.2021 - 28.11.2021

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California. Address: 5200 Illumina Way, San Diego, CA, United States, 92122

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

120.12 USD

P/E ratio

Dividend Yield

Current Year

+4 372 000 000 USD

Last Year

+4 504 000 000 USD

Current Quarter

+1 104 000 000 USD

Last Quarter

+1 080 000 000 USD

Current Year

+2 861 000 000 USD

Last Year

+2 744 000 000 USD

Current Quarter

+728 000 000 USD

Last Quarter

+745 000 000 USD

Key Figures ILMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 701 000 000 USD
Operating Margin TTM -9.60 %
Price to Earnings
Return On Assets TTM 2.64 %
PEG Ratio 0.62
Return On Equity TTM -30.13 %
Wall Street Target Price 120.12 USD
Revenue TTM 4 371 999 744 USD
Book Value 14.93 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -1.60 %
Dividend Yield
Gross Profit TTM 2 988 999 936 USD
Earnings per share -7.69 USD
Diluted Eps TTM -7.69 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY -96.50 %
Profit Margin -27.97 %

Dividend Analytics ILMN

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History ILMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1028:1000
Payout Ratio
Last Split Date 25.06.2024

Stock Valuation ILMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 16.31
Enterprise Value Revenue 2.98
Price Sales TTM 2.66
Enterprise Value EBITDA 51.88
Price Book MRQ 4.90

Financials ILMN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ILMN

For 52 weeks

68.70 USD 156.66 USD
50 Day MA 88.11 USD
Shares Short Prior Month 5 841 687
200 Day MA 122.02 USD
Short Ratio 2.37
Shares Short 5 655 209
Short Percent 4.04 %